PHI-101
Catalog No.
BA8962
PHI-101 is an orally effective inhibitor that overcomes resistance to multiple drug-resistant mutations.
Featured Products
PHI-101 is an orally effective inhibitor that overcomes resistance to multiple drug-resistant mutations.PHI-101 effectively inhibits single-activating mutations (ITD or TKD mutants) and exhibits inhibitory activity against double (ITD/D835Y or ITD/F691L) and triple (ITD/D835Y/F691L) drug-resistant mutations.PHI-101 is expected to be used in the relapsed or refractory acute myeloid leukemia (AML).
Physical Appearance | A solid |
Storage | -20°C |
M.Wt | 386.44 |
Cas No. | 2127107-15-5 |
Formula | C19H19FN4O2S |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |